APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide Delivery Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhaled Nitric Oxide Delivery Device Market Outlook and Growth Opportunities 2026

Report ID 17442563054 July 2026196 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Delivery Device Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Delivery Device Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Delivery Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Delivery Device Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Delivery Device Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhaled Nitric Oxide Delivery Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhaled Nitric Oxide Delivery Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhaled Nitric Oxide Delivery Device market include Air Liquide Healthcare, Bellerophon Therapeutics, Beyond Air, Circassia Pharmaceuticals, Getinge, LINDE, Mallinckrodt Pharmaceuticals, NU MED and Praxair Technology Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhaled Nitric Oxide Delivery Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaled Nitric Oxide Delivery Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaled Nitric Oxide Delivery Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhaled Nitric Oxide Delivery Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhaled Nitric Oxide Delivery Device Segment by Company

Air Liquide Healthcare

Bellerophon Therapeutics

Beyond Air

Circassia Pharmaceuticals

Getinge

LINDE

Mallinckrodt Pharmaceuticals

NU MED

Praxair Technology Inc.

Vero Biotech

Inhaled Nitric Oxide Delivery Device Segment by Type

Inhaled Nitric Oxide Delivery Device for Children

Inhaled Nitric Oxide Delivery Device for Adults

Inhaled Nitric Oxide Delivery Device Segment by Application

Hypoxic Respiratory Failure (HRF)

Chronic Obstructive Pulmonary Disease (COPD)

Acute Hypoxemic Respiratory Failure (AHRF)

Others

Inhaled Nitric Oxide Delivery Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhaled Nitric Oxide Delivery Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhaled Nitric Oxide Delivery Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhaled Nitric Oxide Delivery Device significant trends, drivers, influence factors in global and regions.

6. To analyze Inhaled Nitric Oxide Delivery Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Delivery Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaled Nitric Oxide Delivery Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhaled Nitric Oxide Delivery Device industry.

Chapter 3: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhaled Nitric Oxide Delivery Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhaled Nitric Oxide Delivery Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhaled Nitric Oxide Delivery Device Industry Trends Table 2. Inhaled Nitric Oxide Delivery Device Industry Drivers Table 3. Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges Table 4. Inhaled Nitric Oxide Delivery Device Industry Restraints Table 5. Global Inhaled Nitric Oxide Delivery Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Company (2021-2026) Table 7. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Company (k units) & (2021-2026) Table 8. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Company (2021-2026) Table 9. Global Inhaled Nitric Oxide Delivery Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Inhaled Nitric Oxide Delivery Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhaled Nitric Oxide Delivery Device Key Company Manufacturing Base & Headquarters Table 12. Global Inhaled Nitric Oxide Delivery Device Company, Product Type & Application Table 13. Global Inhaled Nitric Oxide Delivery Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhaled Nitric Oxide Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inhaled Nitric Oxide Delivery Device for Children Table 18. Significant Companies of Inhaled Nitric Oxide Delivery Device for Adults Table 19. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2021-2026) & (k units) Table 21. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2027-2032) & (k units) Table 22. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Type (2021-2026) Table 23. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Type (2027-2032) Table 24. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Type (2021-2026) Table 28. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hypoxic Respiratory Failure (HRF) Table 30. Significant Companies of Chronic Obstructive Pulmonary Disease (COPD) Table 31. Significant Companies of Acute Hypoxemic Respiratory Failure (AHRF) Table 32. Significant Companies of Others Table 33. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2021-2026) & (k units) Table 35. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2027-2032) & (k units) Table 36. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Application (2021-2026) Table 37. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Application (2027-2032) Table 38. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Application (2021-2026) Table 42. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Application (2027-2032) Table 43. Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2026) & (k units) Table 45. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2021-2026) Table 46. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2027-2032) & (k units) Table 47. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2027-2032) Table 48. Global Inhaled Nitric Oxide Delivery Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Region (2021-2026) Table 51. Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Region (2027-2032) Table 53. Global Inhaled Nitric Oxide Delivery Device Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Inhaled Nitric Oxide Delivery Device Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Inhaled Nitric Oxide Delivery Device Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Inhaled Nitric Oxide Delivery Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units) Table 58. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2026) Table 59. Global Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units) Table 60. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2027-2032) Table 61. Global Inhaled Nitric Oxide Delivery Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Inhaled Nitric Oxide Delivery Device Sales Value Market Share by Country (2021-2026) Table 63. Global Inhaled Nitric Oxide Delivery Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Inhaled Nitric Oxide Delivery Device Sales Value Market Share by Country (2027-2032) Table 65. Air Liquide Healthcare Company Information Table 66. Air Liquide Healthcare Business Overview Table 67. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio Table 69. Air Liquide Healthcare Recent Development Table 70. Bellerophon Therapeutics Company Information Table 71. Bellerophon Therapeutics Business Overview Table 72. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio Table 74. Bellerophon Therapeutics Recent Development Table 75. Beyond Air Company Information Table 76. Beyond Air Business Overview Table 77. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio Table 79. Beyond Air Recent Development Table 80. Circassia Pharmaceuticals Company Information Table 81. Circassia Pharmaceuticals Business Overview Table 82. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio Table 84. Circassia Pharmaceuticals Recent Development Table 85. Getinge Company Information Table 86. Getinge Business Overview Table 87. Getinge Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio Table 89. Getinge Recent Development Table 90. LINDE Company Information Table 91. LINDE Business Overview Table 92. LINDE Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio Table 94. LINDE Recent Development Table 95. Mallinckrodt Pharmaceuticals Company Information Table 96. Mallinckrodt Pharmaceuticals Business Overview Table 97. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio Table 99. Mallinckrodt Pharmaceuticals Recent Development Table 100. NU MED Company Information Table 101. NU MED Business Overview Table 102. NU MED Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio Table 104. NU MED Recent Development Table 105. Praxair Technology Inc. Company Information Table 106. Praxair Technology Inc. Business Overview Table 107. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio Table 109. Praxair Technology Inc. Recent Development Table 110. Vero Biotech Company Information Table 111. Vero Biotech Business Overview Table 112. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio Table 114. Vero Biotech Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Inhaled Nitric Oxide Delivery Device Distributors List Table 118. Inhaled Nitric Oxide Delivery Device Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Delivery Device Product Image Figure 2. Global Inhaled Nitric Oxide Delivery Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhaled Nitric Oxide Delivery Device Sales (2021-2032) & (k units) Figure 5. Global Inhaled Nitric Oxide Delivery Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Inhaled Nitric Oxide Delivery Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inhaled Nitric Oxide Delivery Device for Children Image Figure 10. Inhaled Nitric Oxide Delivery Device for Adults Image Figure 11. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Type (2021-2032) Figure 14. Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Inhaled Nitric Oxide Delivery Device Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Type (2021-2032) Figure 17. Hypoxic Respiratory Failure (HRF) Image Figure 18. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 19. Acute Hypoxemic Respiratory Failure (AHRF) Image Figure 20. Others Image Figure 21. Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Application (2021-2032) Figure 24. Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Inhaled Nitric Oxide Delivery Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Application (2021-2032) Figure 27. Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Inhaled Nitric Oxide Delivery Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Inhaled Nitric Oxide Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Inhaled Nitric Oxide Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Inhaled Nitric Oxide Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Inhaled Nitric Oxide Delivery Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Inhaled Nitric Oxide Delivery Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Inhaled Nitric Oxide Delivery Device for Children
  • Inhaled Nitric Oxide Delivery Device for Adults
Applications
  • Hypoxic Respiratory Failure (HRF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Hypoxemic Respiratory Failure (AHRF)
  • Others
Companies covered
  • Air Liquide Healthcare
  • Bellerophon Therapeutics
  • Beyond Air
  • Circassia Pharmaceuticals
  • Getinge
  • LINDE
  • Mallinckrodt Pharmaceuticals
  • NU MED
  • Praxair Technology Inc.
  • Vero Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032)
  4. 1.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume (2021-2032)
  5. 1.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhaled Nitric Oxide Delivery Device Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Delivery Device Industry Trends
  2. 2.2 Inhaled Nitric Oxide Delivery Device Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Delivery Device Industry Restraints
3 Inhaled Nitric Oxide Delivery Device Market by Company
  1. 3.1 Global Inhaled Nitric Oxide Delivery Device Company Revenue Ranking in 2025
  2. 3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Company (2021-2026)
  3. 3.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhaled Nitric Oxide Delivery Device Average Price by Company (2021-2026)
  5. 3.5 Global Inhaled Nitric Oxide Delivery Device Company Ranking (2024-2026)
  6. 3.6 Global Inhaled Nitric Oxide Delivery Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhaled Nitric Oxide Delivery Device Company Product Type and Application
  8. 3.8 Global Inhaled Nitric Oxide Delivery Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhaled Nitric Oxide Delivery Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhaled Nitric Oxide Delivery Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhaled Nitric Oxide Delivery Device Market by Type
  1. 4.1 Inhaled Nitric Oxide Delivery Device Type Introduction
  2. 4.1.1 Inhaled Nitric Oxide Delivery Device for Children
  3. 4.1.2 Inhaled Nitric Oxide Delivery Device for Adults
  4. 4.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type
  5. 4.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Inhaled Nitric Oxide Delivery Device Sales Value by Type
  9. 4.3.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Type (2021-2032)
  11. 4.3.3 Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Type (2021-2032)
5 Inhaled Nitric Oxide Delivery Device Market by Application
  1. 5.1 Inhaled Nitric Oxide Delivery Device Application Introduction
  2. 5.1.1 Hypoxic Respiratory Failure (HRF)
  3. 5.1.2 Chronic Obstructive Pulmonary Disease (COPD)
  4. 5.1.3 Acute Hypoxemic Respiratory Failure (AHRF)
  5. 5.1.4 Others
  6. 5.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application
  7. 5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Inhaled Nitric Oxide Delivery Device Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Inhaled Nitric Oxide Delivery Device Sales Value by Application
  11. 5.3.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Application (2021-2032)
  13. 5.3.3 Global Inhaled Nitric Oxide Delivery Device Sales Value Share by Application (2021-2032)
6 Inhaled Nitric Oxide Delivery Device Regional Sales and Value Analysis
  1. 6.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2032)
  3. 6.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021-2026
  4. 6.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region (2027-2032)
  5. 6.3 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Region (2027-2032)
  9. 6.5 Global Inhaled Nitric Oxide Delivery Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032)
  12. 6.6.2 North America Inhaled Nitric Oxide Delivery Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032)
  15. 6.7.2 Europe Inhaled Nitric Oxide Delivery Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhaled Nitric Oxide Delivery Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032)
  21. 6.9.2 South America Inhaled Nitric Oxide Delivery Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhaled Nitric Oxide Delivery Device Sales Value Share by Country, 2025 VS 2032
7 Inhaled Nitric Oxide Delivery Device Country-level Sales and Value Analysis
  1. 7.1 Global Inhaled Nitric Oxide Delivery Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
  4. 7.3.1 Global Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026)
  5. 7.3.2 Global Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032)
  6. 7.4 Global Inhaled Nitric Oxide Delivery Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhaled Nitric Oxide Delivery Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhaled Nitric Oxide Delivery Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhaled Nitric Oxide Delivery Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhaled Nitric Oxide Delivery Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhaled Nitric Oxide Delivery Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Air Liquide Healthcare
  2. 8.1.1 Air Liquide Healthcare Company Information
  3. 8.1.2 Air Liquide Healthcare Business Overview
  4. 8.1.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
  6. 8.1.5 Air Liquide Healthcare Recent Developments
  7. 8.2 Bellerophon Therapeutics
  8. 8.2.1 Bellerophon Therapeutics Company Information
  9. 8.2.2 Bellerophon Therapeutics Business Overview
  10. 8.2.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
  12. 8.2.5 Bellerophon Therapeutics Recent Developments
  13. 8.3 Beyond Air
  14. 8.3.1 Beyond Air Company Information
  15. 8.3.2 Beyond Air Business Overview
  16. 8.3.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
  18. 8.3.5 Beyond Air Recent Developments
  19. 8.4 Circassia Pharmaceuticals
  20. 8.4.1 Circassia Pharmaceuticals Company Information
  21. 8.4.2 Circassia Pharmaceuticals Business Overview
  22. 8.4.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
  24. 8.4.5 Circassia Pharmaceuticals Recent Developments
  25. 8.5 Getinge
  26. 8.5.1 Getinge Company Information
  27. 8.5.2 Getinge Business Overview
  28. 8.5.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
  30. 8.5.5 Getinge Recent Developments
  31. 8.6 LINDE
  32. 8.6.1 LINDE Company Information
  33. 8.6.2 LINDE Business Overview
  34. 8.6.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
  36. 8.6.5 LINDE Recent Developments
  37. 8.7 Mallinckrodt Pharmaceuticals
  38. 8.7.1 Mallinckrodt Pharmaceuticals Company Information
  39. 8.7.2 Mallinckrodt Pharmaceuticals Business Overview
  40. 8.7.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
  42. 8.7.5 Mallinckrodt Pharmaceuticals Recent Developments
  43. 8.8 NU MED
  44. 8.8.1 NU MED Company Information
  45. 8.8.2 NU MED Business Overview
  46. 8.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
  48. 8.8.5 NU MED Recent Developments
  49. 8.9 Praxair Technology Inc.
  50. 8.9.1 Praxair Technology Inc. Company Information
  51. 8.9.2 Praxair Technology Inc. Business Overview
  52. 8.9.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
  54. 8.9.5 Praxair Technology Inc. Recent Developments
  55. 8.10 Vero Biotech
  56. 8.10.1 Vero Biotech Company Information
  57. 8.10.2 Vero Biotech Business Overview
  58. 8.10.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
  60. 8.10.5 Vero Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhaled Nitric Oxide Delivery Device Value Chain Analysis
  2. 9.1.1 Inhaled Nitric Oxide Delivery Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhaled Nitric Oxide Delivery Device Sales Mode & Process
  6. 9.2 Inhaled Nitric Oxide Delivery Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhaled Nitric Oxide Delivery Device Distributors
  9. 9.2.3 Inhaled Nitric Oxide Delivery Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst